Aarkstore - CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – US
GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in the US. It identifies key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical devices markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
The population of the US in 2013 amounted to 316.1 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.8% from 2008. The country’s increasingly elderly population and corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was worth $326.9 billion in 2008, a value that is expected to have reached $548.4 billion by 2020 at a CAGR of 4.4%. Approximately 86.6% of the US population has healthcare coverage, which has helped to create an efficient healthcare system. New initiatives taken by the Food and Drug Administration (FDA) have strengthened the review and approval process. The value of the US medical device market was $116.2 billion in 2008, and is expected to register a CAGR of 5.0% to reach an estimated $209.7 billion in 2020.
These growth trends can be primarily attributed to -
- Sedentary lifestyles, leading to a high chronic disease burden
- High public healthcare expenditure by the Centers for Medicare and Medicaid...